The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

In both studies, Apretude was compared to Truvada, an HIV PrEP regimen recommended by ... than Truvada for preventing HIV. The main side effects reported by patients receiving Apretude were ...

In June, we heard what could be this year's biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. Findings from a second large study of the jab has now confirmed that it works.

In June, we heard what could be this year’s biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. A ...

Lenacapavir, a bi-annual injectable treatment for HIV prevention (PrEP), is being celebrated as a major advancement in the ...

The benefits of any new medication have to be considered alongside any side effects ... yearly lenacapavir for PrEP worldwide, for all those who want or need PrEP.” HIV experts and health ...

Beyond the hope of new HIV treatments, AI has the ability to provide individualized treatment plans that can lead to more personalized care with fewer side effects ... and PrEP in the communities ...

The White House on Oct. 21 proposed a new regulation under the Affordable Care Act, sometimes referred to as Obamacare, that ...

Pre-exposure prophylaxis (PrEP) with antiretroviral medications is effective in preventing HIV infections. PrEP use has increased between 2013 and 2023. Multiple PrEP medications are available in ...

The results of the studies from OPERA and Trio cohorts add to the growing body of evidence generated over the last three years, showing CAB LA for PrEP is a highly effective option for HIV prevention.